Moderna, Inc. (MRNA)

108,85 +0,96 (+0,89%) Börsenschluss: 04:00PM EDT

Moderna, Inc.

200 Technology Square
Cambridge, MA 02139
United States
617 714 6500
https://www.modernatx.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 5.600

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Stephane Bancel	CEO & Director	4,55M	300,71M	1973
Dr. Stephen Hoge M.D.	President	1,92M	N/A	1977
Mr. James M. Mock	Chief Financial Officer	1,4M	N/A	1977
Ms. Shannon Thyme Klinger	Chief Legal Officer & Corporate Secretary	1,39M	N/A	1971
Dr. Jerh Collins Ph.D.	Chief Technical Operations & Quality Officer	N/A	N/A	1967
Mr. Brad Miller	Chief Information Officer	N/A	N/A	1974
Ms. Lavina Talukdar CFA	Senior VP & Head of Investor Relations	N/A	N/A	N/A
Colleen Hussey	Senior Director of Corporate Communications	N/A	N/A	N/A
Ms. Tracey Franklin	Chief Human Resources Officer	N/A	N/A	1981
Dr. Melanie Ivarsson M.B.A., Ph.D.	Chief Development Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Moderna, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 10. Die grundlegenden Scores sind Audit: 9, Vorstand: 9, Shareholderrechte: 10, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.